Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.66 +0.46 (+1.63%)
Official Closing Price Updated: 7:00 PM EDT, May 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 78,290,120
Open 28.34
Bid (Size) 28.68 (6)
Ask (Size) 28.74 (7)
Prev. Close 28.20
Today's Range 28.23 - 28.75
52wk Range 25.20 - 40.37
Shares Outstanding 5,606,688,356
Dividend Yield 5.72%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Discounted Stocks Poised for a Major Upswing
Explore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon. 
Via InvestorPlace
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
Sometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell. 
Via InvestorPlace

Performance

YTD
-3.60%
-3.60%
1 Month
+9.10%
+9.10%
3 Month
+3.24%
+3.24%
6 Month
-6.03%
-6.03%
1 Year
-24.24%
-24.24%

More News

Read More
3 Stocks to Buy for Huge Income
Via The Motley Fool
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
From Takeda Pharmaceutical Company Limited
Via Business Wire
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
From Pfizer Inc.
Via Business Wire
Is Pfizer the Best Dividend Stock for You?
Via The Motley Fool
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer
Via Benzinga
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Via Investor's Business Daily
Exposures Product Safety
How To Earn $500 A Month From Pfizer Stock
Via Benzinga
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
From Pfizer Inc.
Via Business Wire
Ginkgo Bioworks Stock: Bull vs. Bear
Via The Motley Fool
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
Via The Motley Fool
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
Via AB Newswire
Exposures COVID-19
Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine
Via Investor's Business Daily
Beat the Dow Jones With This Cash-Gushing Dividend Stock
Via The Motley Fool
Topics Stocks
Exposures US Equities
Steady Gains, Solid Yields: 7 Low-Beta Stocks Paying 5%+ Dividends
Via InvestorPlace
3 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
Via Benzinga
Topics Economy Retirement
Exposures Economy Pension
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Via The Motley Fool
7 Must-Own Stocks to Hold for the Second Half of 2024
Via InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Exposures Product Safety
If You Can Only Buy One Value Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
Via Benzinga
Exposures Product Safety
Revenge of the Apes: 3 Reddit WallStreetBets Stocks That Could Pop Next
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.